Treatment of heart failure in nursing home residents

作     者：Marielle AMJ Daamen Jan PH Hamers Anton PM Gorgels Frans ES Tan Jos MGA Schols Hans-Peter Bmnner-la Rocca 

作者机构：Department of Health Services Research Research School CAPHRI Maastricht University Maastricht the Netherlands Department of Cardiology Maastricht University Medical Center Maastricht the Netherlands Department of Methodology and Statistics Research School CAPHRI Maastricht University Maastricht the Netherlands Department of Family Medicine Research School CAPHRI Maastricht University Maastricht the Netherlands 

出 版 物：《Journal of Geriatric Cardiology》 (老年心脏病学杂志（英文版）)

年 卷 期：2016年第13卷第1期

页      面：44-50页

核心收录：

学科分类：1001[医学-基础医学(可授医学、理学学位)] 10[医学] 

基　　金：Noneoftheauthorshaveanycompetinginterestsarisingfromthisresearch.anunrestrictedgrantfromtheDutchOrganizationforHealthResearchandDevelopment(ZonMw)(grantnumber60-61900-98-303) 

主　　题：Ejection fraction Heart failure Nursing home Treatment 

摘      要：BackgroundFor the treatment of chronic heart failure （HF）, both pharmacological and non-pharmacological treatment should be em-ployed in HF patients. Although HF is highly prevalent in nursing home residents, it is not clear whether the recommendations in the guide-lines for pharmacological therapy also are followed in nursing home residents. The aim of this study is to investigate how HF is treated in nursing home residents and to determine to what extent the current treatment corresponds to the *** home resi-dents of five large nursing home care organizations in the southern part of the Netherlands with a previous diagnosis of HF based on medical records irrespective of the left ventricle ejection fraction （LVEF） were included in this cross-sectional design study. Data were gathered on the （medical） records, which included clinical characteristics and pharmacological- and non-pharmacological treatment. Echocardiography was used as part of the study to determine the *** of 501 residents, 112 had a diagnosis of HF at inclusion. One-third of them received an ACE-inhibitor and 40% used aβ-blocker. In 66%, there was a prescription of diuretics with a preference of a loop diuretic. Focusing on the residents with a LVEF￡ 40%, only 46% of the 22 residents used an ACE-inhibitor and 64% aβ-blocker. The median daily doses of prescribed medication were lower than those that were recommended by the guidelines. Non-pharmacological interventions were recorded in almost none of the residents with *** recommended medical therapy of HF was often not prescribed; if pre-scribed, the dosage was usually far below what was recommended. In addition, non-pharmacological interventions were mostly not used at all.